.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Teva Parenteral Company Profile

« Back to Dashboard

Summary for Applicant: Teva Parenteral

Patents:0
Tradenames:40
Ingredients:38
NDAs:48
Drug Master File Entries: (click here to view)362
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Parenteral
BUMETANIDE
bumetanide
INJECTABLE;INJECTION074613-001Nov 18, 1997DISCNNo<disabled><disabled>
Teva Parenteral
IDARUBICIN HYDROCHLORIDE
idarubicin hydrochloride
INJECTABLE;INJECTION065037-001May 1, 2002DISCNNo<disabled><disabled>
Teva Parenteral
SUMATRIPTAN SUCCINATE
sumatriptan succinate
INJECTABLE;SUBCUTANEOUS078318-002Feb 6, 2009DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc